![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » AstraZeneca Mulls Vaccine Sale After $12.5bn MedImmune Deal
AstraZeneca Mulls Vaccine Sale After $12.5bn MedImmune Deal
April 26, 2007
AstraZeneca is already
considering offloading MedImmune's vaccines business, just days after it paid
$15.2bn (£7.6bn, E11.2bn) for the US biotech.
The
Business
KEYWORDS Deals
Upcoming Events
-
21Oct